20 articles
32-person study explores how intermittent fasting affects blood vessel function and brain performance through protective pathways.
King's College study tests whether simple chewing and fasting patterns can enhance cognitive function and neurogenesis in older adults.
Study tests whether fasting before or after soccer heading reduces brain injury markers and cognitive impairment in college athletes.
Combining Mediterranean-DASH diet with nature therapy targets hypertension and cognitive decline in older adults.
Age-tailored cognitive behavioral intervention tested in 20 older women with binge eating disorder in pilot study.
180-person study explores whether Mediterranean eating patterns can prevent cognitive decline in overweight seniors.
Large 6-year study tested dietary interventions including caloric restriction and omega-3s in 330 people with mild cognitive impairment.
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
60-patient trial explores whether metformin, combined with standard therapy, could slow Parkinson's progression through metabolic pathways.
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
A Phase 2 open-label trial explores whether an approved immune drug can raise frataxin protein levels and slow neurological decline in Friedreich Ataxia.
A Phase 3 trial investigates whether the GLP-1 drug liraglutide can slow cognitive decline in T2DM patients at elevated Alzheimer's risk.
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
UC San Diego researchers tested psilocybin's safety and potential benefits for eating disorder symptoms in 16 participants with anorexia nervosa.
Personalized treatment approach targeting multiple causes of cognitive decline outperformed standard care in 9-month trial.
The EPICURO trial tests MERIVA® turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
Clinical trial explores whether resetting gut microbiome through fecal transplants can slow Parkinson's progression and reduce symptoms.
A completed trial tests EGCG combined with diet, exercise, and cognitive training to slow decline in ApoE4 carriers with early warning signs.
Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.
Novel movement program combining Eastern and Western exercises may help maintain independence and cognitive function in dementia patients.
